Example: tourism industry
SC - chm.pops.int
An addendum to that evaluation was adopted at its fourth meeting. ... The cost and the efficiency of alternatives would require further investigation. ... Annually, about 25 tonnes of PFOS-containing chromium fog inhibitor are used in the Chinese chrome plating industry, with the value of 30 billion Yuan. ...
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
SC-4/18: Listing of tetrabromodiphenyl ether and ...
chm.pops.intSC-4/18: Listing of tetrabromodiphenyl ether and pentabromodiphenyl ether The Conference of the Parties, Having considered the risk profile and risk management evaluation for commercial pentabromodiphenyl ether transmitted by the Persistent Organic Pollutants Review Committee,1 Taking note of the recommendation by the Persistent Organic Pollutants Review Committee to
STOCKHOLM CONVENTION ON PERSISTENT ORGANIC …
chm.pops.intconventions, especially the Rotterdam Convention on the Prior Informed Consent Procedure for Certain Hazardous Chemicals and Pesticides in International Trade, and the Basel Convention on the Control of Transboundary Movements of Hazardous Wastes and their Disposal including the regional agreements developed within the framework of its Article 11,
Related documents
MATERIALS SELECTION - Standard
www.standard.noEvaluation of corrosivity shall as a minimum include: ... For pipelines, an inhibitor efficiency of 85 % shall be used for design, including effect of glycol and/or methanol injection. The inhibitor efficiency shall be qualified and documented by corrosion
Recombinant Protein Expression & Purification ...
www.genscript.comProduction efficiency ... proteins and deliver expression evaluation report to the customer. Make Research Easy Case Study: Membrane Protein 30 WB analysis of the membrane preparation 1. Whole cell lysate of GPCR before sonication ... • Add protease inhibitor to every step • Optimize buffer components
M07: Methods for Dilution Antimicrobial Susceptibility ...
community.clsi.orgCLSI documents undergo periodic evaluation and modification to keep pace with advances in technologies, procedures, methods, and protocols affecting the laboratory or health care. CLSI’s consensus process depends on experts who volunteer to serve as contributing authors and/or as participants in the reviewing and commenting process.